CATURANO, ALFREDO
 Distribuzione geografica
Continente #
AS - Asia 2.434
NA - Nord America 144
EU - Europa 65
SA - Sud America 36
OC - Oceania 12
AF - Africa 9
Totale 2.700
Nazione #
SG - Singapore 2.378
US - Stati Uniti d'America 109
BR - Brasile 30
HK - Hong Kong 26
MX - Messico 21
DE - Germania 19
IT - Italia 15
CA - Canada 13
GB - Regno Unito 13
IN - India 8
AU - Australia 7
IE - Irlanda 7
PL - Polonia 7
ZA - Sudafrica 7
NZ - Nuova Zelanda 5
VN - Vietnam 5
BD - Bangladesh 4
JP - Giappone 4
AR - Argentina 2
CO - Colombia 2
PK - Pakistan 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
ID - Indonesia 1
KR - Corea 1
NL - Olanda 1
SE - Svezia 1
TR - Turchia 1
VE - Venezuela 1
Totale 2.700
Città #
Singapore 168
Hong Kong 26
Mexico City 19
Munich 16
Ashburn 10
Los Angeles 8
New York 8
São Paulo 8
Brooklyn 5
Dublin 5
Johannesburg 5
Naples 5
Santa Clara 5
Warsaw 5
Chennai 4
San Francisco 4
Auckland 3
Boston 3
Chicago 3
Dallas 3
Goiânia 3
Hanoi 3
Melbourne 3
Montreal 3
Okayama 3
Toronto 3
Atlanta 2
Boardman 2
Charlotte 2
Council Bluffs 2
Lahore 2
Olsztyn 2
Poplar 2
Riyadh 2
Sydney 2
Aberdeen 1
Almeirim Municipality 1
Amaraji 1
Amsterdam 1
Ankara 1
Annapolis 1
Araraquara 1
Baltimore 1
Bandar Seri Begawan 1
Batna City 1
Bauru 1
Bedlington 1
Bofete 1
Bogotá 1
Bolton 1
Bridgeport 1
Brisbane 1
Cape Town 1
Cavan 1
Caxias do Sul 1
Chariton 1
Charleston 1
Cologne 1
Coronel Dorrego 1
Demak 1
Denver 1
Dhaka 1
Dubai 1
East Gwillimbury 1
El Tigre 1
Enniscorthy 1
Erechim 1
Exmouth 1
Frankfurt am Main 1
Granby 1
Haiphong 1
Hamilton 1
Helena 1
Ho Chi Minh City 1
Houston 1
Itaquaquecetuba 1
Jacareí 1
Jacksonville 1
Juneau 1
Kozhikode 1
Lac-Beauport 1
Lansing 1
Laurel 1
London 1
Londrina 1
Longfield 1
Mauá 1
Memphis 1
Miami 1
Milan 1
Minsk 1
Mumbai 1
Napanee 1
Oklahoma City 1
Opa-locka 1
Orangeville 1
Ourinhos 1
Pasadena 1
Perham 1
Perth 1
Totale 414
Nome #
Advances in Nanomedicine for Precision Insulin Delivery 201
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin 199
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 199
The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern 197
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 197
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 196
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 193
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 192
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 191
Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? 190
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 185
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 91
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 30
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 13
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 12
Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications 10
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 10
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 10
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 9
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 9
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study 9
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 8
Metformin for Type 2 Diabetes 8
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 8
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 8
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 8
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 8
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 8
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation 8
Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants 8
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 7
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 7
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study 7
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 7
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 7
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 7
Brugada syndrome and COVID-19 vaccines 6
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 6
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 6
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 6
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 6
Polypharmacy and Major Adverse Events in Atrial Fibrillation 6
Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 6
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 6
Sarcopenic obesity and weight loss-induced muscle mass loss 6
Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma 6
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 6
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 6
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 6
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 6
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 6
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 6
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 6
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 6
Post-fracture thromboprophylaxis: is it time for a change? 6
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 6
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 6
HCC and molecular targeting therapies: Back to the future 6
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 6
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 6
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 6
Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality 6
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 6
Insulin resistance and cancer: molecular links and clinical perspectives 6
Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 6
Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects 5
Advancements in Cardiovascular and Antidiabetic Drug Therapy 5
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 5
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 5
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 5
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 5
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 5
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk 5
Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development 5
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 5
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 5
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 5
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 5
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 5
Impact of sglt2 inhibitors on heart failure: From pathophysiology to clinical effects 5
HAND GRIP STRENGTH EVALUATION IN RHEUMATOLOGIC DISEASES 5
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 5
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 4
Cardiovascular benefits from gliflozins: Effects on endothelial function 4
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 4
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 4
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 4
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 4
New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo 4
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 4
Statin Effect on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients on Hemodialysis 4
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 4
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact 4
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 4
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0 4
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 4
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 4
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 4
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study 4
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 4
Totale 2.788
Categoria #
all - tutte 8.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.593 0 0 0 0 0 0 4 18 2 227 1.264 1.078
2025/2026228 192 36 0 0 0 0 0 0 0 0 0 0
Totale 2.821